Research & Development
Projects Driving Medical Progress
From concept to clinic — our portfolio spans cardiovascular devices, metabolic therapeutics, and diagnostic platforms at varying stages of development.
Research & Development
Active Programs
Conductance Balloon Coronary Post-Dilatation Catheter
Stent malapposition leads to less optimal outcomes (restenosis and thrombosis) in coronary stenting. 3DT is developing a novel conductance balloon (CB) coronary post-dilatation catheter system (the CB catheter) that accurately measures and displays real-time balloon size. The device provides an innovative, clinically-relevant, real-time, simple, accurate, repeatable, and objective sizing measurement during coronary post-dilatation to aid in stent deployment and proper minimum stent area (MSA) / minimum stent diameter (MSD) determination.
Stage
Preclinical → Phase II
Indication
Coronary Artery Disease
Pathway
FDA 510(k)
All Projects
Active
Conductance Balloon Coronary Post-Dilatation Catheter
Stent malapposition leads to less optimal outcomes (restenosis and thrombosis) in coronary stenting.
Active
Stabilization Device for Trans-septal Access
Transseptal (TS) procedures for accessing the left side of the heart are an important and rapidly growing space for diagnostics and therapy delivery.
Active
Mild Hypothermia Catheter for Reperfusion Injury
ST segment elevation myocardial infarction (STEMI) is the most severe form of acute coronary syndrome (ACS) that affects nearly 500,000 Americans each year and places a heavy clinical and financial burden on the healthcare system.
Active
Valvuloplasty
Aortic stenosis (AS) affects approximately 1.5 million Americans and places a large financial burden on the U.S. healthcare system.
Active
Patent Portfolio
3DT owns a portfolio of over 200 issued and pending patents that cover inventions in the areas of electrical conductance-enabled therapeutic devices, retroperfusion-enabling devices,
Active
NIH Sponsored Research
3DT is a recipient of National Institutes of Health (NIH) research grants. 3DT has policies and procedures in place to support these grants and ensure compliance with federal regulations including
CONTACT US
Say Hello to Us
Our team is open to co-development agreements, contract research engagements, and investment discussions with qualified B2B partners and institutional investors.